HARRY SKIP KIIL - 21 May 2025 Form 3 Insider Report for Medtronic plc (MDT)

Role
EVP & President Cardiovascular
Signature
/s/ Thomas L. Osteraas, attorney-in-fact
Issuer symbol
MDT
Transactions as of
21 May 2025
Net transactions value
$0
Form type
3
Filing time
04 Jun 2025, 16:29:12 UTC
Next filing
30 Jul 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
KIIL HARRY SKIP EVP & President Cardiovascular 710 MEDTRONIC PARKWAY, MINNEAPOLIS /s/ Thomas L. Osteraas, attorney-in-fact 04 Jun 2025 0001708062

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MDT Ordinary Shares 33,442 21 May 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MDT Stock Option (Right to Buy) 21 May 2025 Ordinary Shares 34,934 $112.43 Direct F2
holding MDT Stock Option (Right to Buy) 21 May 2025 Ordinary Shares 42,174 $93.08 Direct F2
holding MDT Stock Option (Right to Buy) 21 May 2025 Ordinary Shares 38,849 $87.76 Direct F2
holding MDT Stock Option (Right to Buy) 21 May 2025 Ordinary Shares 1,540 $80.00 Direct F2
holding MDT Performance Share Unit 21 May 2025 Ordinary Shares 14,146 Direct F3, F4, F5
holding MDT Performance Share Unit 21 May 2025 Ordinary Shares 14,517 Direct F5, F6, F7
holding MDT Performance Share Unit 21 May 2025 Ordinary Shares 4,806 Direct F5, F8, F9
holding MDT Performance Share Unit 21 May 2025 Ordinary Shares 15,378 Direct F5, F10, F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 2,200 restricted stock units that vested on December 6, 2024; 5,658 restricted stock units that vest on August 1, 2025; 2,200 restricted stock units that vest on December 6, 2025; 5,807 restricted stock units that vest of July 31, 2026; 2,199 restricted stock units that vest on December 6, 2026; and 15,378 restricted stock units that vest on July 29, 2027.
F2 These options became exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.
F3 The performance share units vest on August 1, 2025.
F4 The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 14,146 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
F5 Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
F6 The performance share units vest on April 26, 2026.
F7 The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 14,517 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
F8 The performance share units vest on December 6, 2026.
F9 The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 4,806 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
F10 The performance share units vest on April 30, 2027.
F11 The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 15,378 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.